These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15193830)

  • 61. Sensitivity and specificity of sodium channel blocking test in the diagnosis of Brugada syndrome.
    Gavrielatos G; Letsas KP; Pappas LK; Efremidis M; Sideris A; Kardaras F
    Int J Cardiol; 2010 May; 141(2):e31-3. PubMed ID: 19141363
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mechanism of ST elevation and ventricular arrhythmias in an experimental Brugada syndrome model.
    Kimura M; Kobayashi T; Owada S; Ashikaga K; Higuma T; Sasaki S; Iwasa A; Motomura S; Okumura K
    Circulation; 2004 Jan; 109(1):125-31. PubMed ID: 14662710
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Role of sodium and calcium channel block in unmasking the Brugada syndrome.
    Fish JM; Antzelevitch C
    Heart Rhythm; 2004 Jul; 1(2):210-7. PubMed ID: 15851155
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Body surface potential mapping in patients with Brugada syndrome: right precordial ST segment variations and reverse changes in left precordial leads.
    Bruns HJ; Eckardt L; Vahlhaus C; Schulze-Bahr E; Haverkamp W; Borggrefe M; Breithardt G; Wichter T
    Cardiovasc Res; 2002 Apr; 54(1):58-66. PubMed ID: 12062362
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Normal variability of the peak-to-trough amplitude of isointegral QRST body surface maps.
    Ruttkay-Nedecký I; Regecová V
    J Electrocardiol; 2002 Oct; 35(4):327-32. PubMed ID: 12395360
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Brugada by any other name?
    Martini B; Cannas S; Nava A
    Eur Heart J; 2001 Oct; 22(19):1835-6. PubMed ID: 11549306
    [No Abstract]   [Full Text] [Related]  

  • 67. Effectiveness of sotalol treatment in symptomatic Brugada syndrome.
    Glatter KA; Wang Q; Keating M; Chen S; Chiamvimonvat N; Scheinman MM
    Am J Cardiol; 2004 May; 93(10):1320-2. PubMed ID: 15135718
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Abnormal response to sodium channel blockers in patients with Brugada syndrome: augmented localised wall motion abnormalities in the right ventricular outflow tract region detected by electron beam computed tomography.
    Takagi M; Aihara N; Kuribayashi S; Taguchi A; Kurita T; Suyama K; Kamakura S; Takamiya M
    Heart; 2003 Feb; 89(2):169-74. PubMed ID: 12527670
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Variation of body surface QRST isointegral map in patients with idiopathic long QT syndrome].
    Nirei T
    Nihon Rinsho; 1995 Jan; 53(1):139-44. PubMed ID: 7897833
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Brugada syndrome.
    Wilde AA; Remme CA; Derksen R; Wever EF; Hauer RN
    Eur Heart J; 2002 Apr; 23(8):675-6. PubMed ID: 11969283
    [No Abstract]   [Full Text] [Related]  

  • 71. ECG body surface isointegral and isoarea maps (BSM) in 30 and 60-years-old healthy humans.
    Slavícek J; Kittnar O; Novák V; Trefný Z; Horácek BM
    Sb Lek; 2001; 102(3):369-74. PubMed ID: 12092122
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Body surface mapping after partial left ventriculotomy.
    Trobec R; Gersak B; Hren R
    Heart Surg Forum; 2002; 5(2):187-92. PubMed ID: 12125671
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Effect of the sympathetic nervous system activation on the antifibrillatory efficacy of various anti-arrhythmia agents].
    Kaverina NV; Chichkanov GG; Tsorin IB; Kirsanova GIu
    Eksp Klin Farmakol; 2000; 63(6):22-3. PubMed ID: 11202504
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Brugada syndrome: historical perspectives and observations.
    Antzelevitch C
    Eur Heart J; 2002 Apr; 23(8):676-8. PubMed ID: 11969284
    [No Abstract]   [Full Text] [Related]  

  • 75. Effects of glucose-induced insulin secretion on ST segment elevation in the Brugada syndrome.
    Nishizaki M; Sakurada H; Ashikaga T; Yamawake N; Fujii H; Arita M; Isobe M; Hiraoka M
    J Cardiovasc Electrophysiol; 2003 Mar; 14(3):243-9. PubMed ID: 12716104
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Characteristics of body surface mapping in the cases of idiopathic ventricular fibrillation].
    Toyoshima Y; Nirei T; Kasanuki H; Hosoda S
    Nihon Rinsho; 1995 Jan; 53(1):168-73. PubMed ID: 7897837
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Electrocardiographic findings in arrhythmogenic right ventricular dysplasia (ARVD) evaluated by body surface mapping].
    Okano Y
    Nihon Rinsho; 1995 Jan; 53(1):230-8. PubMed ID: 7897849
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Concept of activation recovery interval and clinical usefulness of body surface recovery time and recovery time isochrone map].
    Shimizu W
    Nihon Rinsho; 1995 Jan; 53(1):74-81. PubMed ID: 7897859
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Are all sodium channel blockers created equal? Clinical-basic correlations based on observations in Brugada syndrome.
    Nattel S
    Heart Rhythm; 2005 Mar; 2(3):261-2. PubMed ID: 15851315
    [No Abstract]   [Full Text] [Related]  

  • 80. [Isochrone map, its implication and clinical usefulness].
    Miyashita T; Okano Y
    Nihon Rinsho; 1995 Jan; 53(1):48-55. PubMed ID: 7897854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.